* Repligen Corp RGEN.OQ RGEN.O is expected to show a
rise in
quarterly revenue when it reports results on November 1.
* The Waltham Massachusetts-based company is expected to
report
a 7.5% increase in revenue to $191.497 million from $178.22
million a year ago, according to the mean estimate from 9
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Repligen Corp is
for
earnings of 68 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 8 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Repligen
Corp is
$274, above its last closing price of $180.71.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Jun. 30 2022 0.72 0.72 0.91 Beat 27
Mar. 31 2022 0.72 0.72 0.92 Beat 27.8
Dec. 31 2021 0.65 0.65 0.81 Beat 24.9
Sep. 30 2021 0.64 0.64 0.78 Beat 22.6
Jun. 0.52 0.52 0.79 Beat 50.8
30 2021
Mar. 31 2021 0.42 0.42 0.68 Beat 60.9
Dec. 31 2020 0.31 0.31 0.52 Beat 69.8
Sep. 30 2020 0.28 0.28 0.40 Beat 44.8
This summary was machine generated October 28 at 16:31 GMT. All
figures in US dollars unless otherwise stated